150 related articles for article (PubMed ID: 25610161)
1. Coronary vasospasm secondary to 5-Fluorouracil and its management: case report.
Yildirim M; Parlak C; Sezer C; Eryilmaz R; Kaya C; Yildiz M
Eurasian J Med; 2011 Apr; 43(1):54-6. PubMed ID: 25610161
[TBL] [Abstract][Full Text] [Related]
2. Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
Chakrabarti S; Sara J; Lobo R; Eiring R; Finnes H; Mitchell J; Hartgers M; Okano A; Halfdanarson T; Grothey A
Clin Colorectal Cancer; 2019 Mar; 18(1):52-57. PubMed ID: 30396850
[TBL] [Abstract][Full Text] [Related]
3. Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion.
Redman JM; Rhea LP; Brofferio A; Whelpley M; Gulley JL; Gatti-Mays ME; McMahon S; Cordes LM; Strauss J
J Gastrointest Oncol; 2019 Oct; 10(5):1010-1014. PubMed ID: 31602339
[TBL] [Abstract][Full Text] [Related]
4. 5-fluorouracil-induced coronary vasospasm.
Shoemaker LK; Arora U; Rocha Lima CM
Cancer Control; 2004; 11(1):46-9. PubMed ID: 14749623
[TBL] [Abstract][Full Text] [Related]
5. Prinzmetal angina (Coronary vasospasm) associated with 5-fluorouracil chemotherapy.
Ben-Yakov M; Mattu A; Brady WJ; Dubbs SB
Am J Emerg Med; 2017 Jul; 35(7):1038.e3-1038.e5. PubMed ID: 28283339
[TBL] [Abstract][Full Text] [Related]
6. Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.
Chong JH; Ghosh AK
Interv Cardiol; 2019 May; 14(2):89-94. PubMed ID: 31178935
[TBL] [Abstract][Full Text] [Related]
7. Reintroduction of 5-Fluorouracil Post-cardiac Arrest Secondary to Chemotherapy-Induced Cardiotoxicity.
Wu K; Bhattacharya P
Cureus; 2023 Jan; 15(1):e34232. PubMed ID: 36852353
[TBL] [Abstract][Full Text] [Related]
8. Rare Presentation of Cardiotoxicity Related to 5-Fluorouracil.
Charkviani M; Murvelashvili N; Barrera F; Sharma A; Eldin RS; Nabil NUN
Case Rep Oncol Med; 2020; 2020():4151474. PubMed ID: 32774961
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
10. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
Shaib W; Lee V; Saif MW
In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
[TBL] [Abstract][Full Text] [Related]
11. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Lokich JJ; Moore CL; Anderson NR
Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
[TBL] [Abstract][Full Text] [Related]
12. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
Ray JC; Cho P; Dragon M; Graham CG
J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms.
Faheem B; Kania B; Ashkar H; Bondili L; Maroules M
J Community Hosp Intern Med Perspect; 2022; 12(5):71-74. PubMed ID: 36262502
[TBL] [Abstract][Full Text] [Related]
14. Successful infusional 5-fluorouracil administration in a patient with vasospastic angina.
Tai S; Mohananey D; Griffiths C; Johnson B; Garg J; Ridolfi TJ; Lohr NL; Chakrabarti S; Brown SA
Am Heart J Plus; 2022 May; 17():. PubMed ID: 36051246
[TBL] [Abstract][Full Text] [Related]
15. Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen.
Cerny J; Hassan A; Smith C; Piperdi B
Clin Colorectal Cancer; 2009 Jan; 8(1):55-8. PubMed ID: 19203898
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity of 5-flourouracil: two case reports.
Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
Karakulak UN; Aladağ E; Maharjan N; Övünç K
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge.
Medepalli LC; Mahmood TS; Liberman H; Medepalli AM; Bagwell TW
Cureus; 2022 Oct; 14(10):e30489. PubMed ID: 36415417
[TBL] [Abstract][Full Text] [Related]
20. The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm.
Zafar A; Drobni ZD; Mosarla R; Alvi RM; Lei M; Lou UY; Raghu VK; Murphy SP; Jones-O'Connor M; Hartmann S; Gilman HK; Weekes CD; Clark JR; Clark J; Blaszkowsky L; Tavares E; Neilan TG
JACC CardioOncol; 2021 Mar; 3(1):101-109. PubMed ID: 33817666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
